‘In summary, current evidence from all available studies including in vitro, in vivo, and epidemiological studies does not indicate an association between MP use and tumors developing from the most exposed organs and tissues. Given the large amount of research on this topic, any potentially undetected risk is expected to be small from an individual perspective and might concern long latency periods (>15 years), rare brain tumor subtypes, and MP usage during childhood. To address such small risks, high-quality research with accurate exposure assessment is needed, taking into account that MP call duration alone is not expected to adequately reject RF-EMF exposure to the brain.’
(https://www.annualreviews.org/doi/10.1146/annurev-publhealth-040218-044037)
ALARM am 3. Oktober! Wie AT-Alert funktioniert und was man dabei beachten muss
Wie man im Notfall alle Warnungen sicher empfängt / FMK beantwortet anlässlich des AT-Alert-Probealarms die brennendsten Fragen der Einwohner:innen Österreichs
